Alexion Pharm Inc (ALXN) Forecast, Price Target & Analyst Ratings
NASDAQ:ALXN
182.5
+3.05 (+1.7%)
At close: Jul 20, 2021
183
+0.5 (+0.27%)
After Hours: 7/20/2021, 9:56:13 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for Alexion Pharm Inc (ALXN).
Forecast Snapshot
Consensus Price Target
$180.90
-0.87% Downside
Next Earnings Forecast
Release DateFeb 22, 2022
PeriodQ2 / 2021
EPS Estimate$3.39
Revenue Estimate1.671B
ChartMill Buy Consensus
66.20%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$180.90
Upside
-0.87%
From current price of $182.50 to mean target of $180.90, Based on 13 analyst forecasts
Low
$167.66
Median
$178.50
High
$215.25
Price Target Revisions
1 Month
N/A
3 Months
N/A
Price Target Summary
13 analysts have analysed ALXN and the average price target is 180.9 null. This implies a price decrease of -0.87% is expected in the next year compared to the current price of 182.5.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
66.20%
ALXN was analyzed by 13 analysts. The buy percentage consensus is at 66. So analysts seem to be have mildly positive about ALXN.
In the previous month the buy percentage consensus was at a similar level.
ALXN was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
Release DateFeb 22, 2022
PeriodQ2 / 2021
EPS Estimate$3.39
Revenue Estimate1.671B
Revenue Q2Q28.70%
EPS Q2Q9.15%
Number of Analysts18
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
ALXN is expected to report earnings on 2/22/2022. The consensus EPS estimate for the next earnings is 3.39 null and the consensus revenue estimate is 1.67B null.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A 18.57% | N/A 13.93% | N/A 15.30% | N/A 21.37% | N/A 21.57% | N/A 12.08% | N/A 7.59% | N/A 7.06% | N/A 5.74% | N/A 7.32% | |
| EBITDA YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | 5.01 | 4.73 -5.59% | 5.86 23.89% | 7.91 34.98% | 10.53 33.12% | 12.53 18.99% | N/A 9.86% | N/A 6.21% | N/A 9.91% | N/A 5.94% | N/A |
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q2 / 21 | Q3 / 21 | Q4 / 21 | Q1 / 22 | Q2 / 22 | Q3 / 22 | Q4 / 22 | |
|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 3.39 9.15% | 3.46 6.67% | 3.41 15.23% | 3.68 4.51% | 3.79 11.72% | 3.82 10.62% | 3.91 14.72% |
| Revenue Q2Q % growth | 1.671B 28.70% | 1.732B 19.66% | 1.776B 15.23% | 1.777B 10.59% | 1.83B 9.54% | 1.883B 8.73% | 1.925B 8.39% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
8.65%
EPS Next 5 Year
6.32%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
8.89%
Revenue Next 5 Year
7.94%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
Alexion Pharm Inc / ALXN Forecast FAQ
Can you provide the average price target for Alexion Pharm Inc stock?
13 analysts have analysed ALXN and the average price target is 180.9 null. This implies a price decrease of -0.87% is expected in the next year compared to the current price of 182.5.
When does Alexion Pharm Inc (ALXN) report earnings?
Alexion Pharm Inc (ALXN) will report earnings on 2022-02-22, before the market open.
What are the consensus estimates for ALXN stock next earnings?
The consensus EPS estimate for the next earnings of Alexion Pharm Inc (ALXN) is 3.39 null and the consensus revenue estimate is 1.67B null.
What is the expected long term growth rate for Alexion Pharm Inc (ALXN)?
The expected long term growth rate for Alexion Pharm Inc (ALXN) is 8.89%.